Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The molecular logic of endocannabinoid signalling.

Piomelli D.

Nat Rev Neurosci. 2003 Nov;4(11):873-84. Review. No abstract available.

PMID:
14595399
2.

The brain's own marijuana.

Nicoll RA, Alger BE.

Sci Am. 2004 Dec;291(6):68-75. No abstract available.

PMID:
15597982
3.

Retrograde signalling by endocannabinoids.

Vaughan CW, Christie MJ.

Handb Exp Pharmacol. 2005;(168):367-83. Review.

PMID:
16596781
5.

Metabotropic suppression of excitation in murine autaptic hippocampal neurons.

Straiker A, Mackie K.

J Physiol. 2007 Feb 1;578(Pt 3):773-85. Epub 2006 Nov 16.

6.

Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue.

Ryan D, Drysdale AJ, Pertwee RG, Platt B.

Eur J Neurosci. 2007 Apr;25(7):2093-102.

PMID:
17419758
7.
8.

Presynaptic modulation by endocannabinoids.

Lovinger DM.

Handb Exp Pharmacol. 2008;(184):435-77. Review.

PMID:
18064422
9.

Endocannabinoids and synaptic function in the CNS.

Hashimotodani Y, Ohno-Shosaku T, Kano M.

Neuroscientist. 2007 Apr;13(2):127-37. Review.

PMID:
17404373
10.

The endocannabinoid system: emotion, learning and addiction.

Moreira FA, Lutz B.

Addict Biol. 2008 Jun;13(2):196-212. doi: 10.1111/j.1369-1600.2008.00104.x. Epub 2008 Apr 16. Review.

PMID:
18422832
11.

The endocannabinoid system and its therapeutic exploitation.

Di Marzo V, Bifulco M, De Petrocellis L.

Nat Rev Drug Discov. 2004 Sep;3(9):771-84. Review.

PMID:
15340387
12.

Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis.

Steiner MA, Wotjak CT.

Prog Brain Res. 2008;170:397-432. doi: 10.1016/S0079-6123(08)00433-0. Review.

PMID:
18655899
13.

Role of endocannabinoids in 5-HT2 receptor-mediated effects.

Connelly WM, Baggott MJ.

J Neurophysiol. 2009 Jan;101(1):5-7. doi: 10.1152/jn.91054.2008. Epub 2008 Nov 12.

14.

Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum.

Rossi S, De Chiara V, Musella A, Kusayanagi H, Mataluni G, Bernardi G, Usiello A, Centonze D.

J Neurosci. 2008 Jul 16;28(29):7284-92. doi: 10.1523/JNEUROSCI.5346-07.2008.

15.

Neuromodulatory functions of the endocannabinoid system.

Marsicano G, Lutz B.

J Endocrinol Invest. 2006;29(3 Suppl):27-46. Review.

PMID:
16751707
16.

Neuromodulation via conditional release of endocannabinoids in the spinal locomotor network.

Kettunen P, Kyriakatos A, Hallén K, El Manira A.

Neuron. 2005 Jan 6;45(1):95-104.

17.

Cannabis and psychiatric disorders: it is not only addiction.

Leweke FM, Koethe D.

Addict Biol. 2008 Jun;13(2):264-75. doi: 10.1111/j.1369-1600.2008.00106.x. Review.

PMID:
18482435
18.

Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.

Mackie K.

Int J Obes (Lond). 2006 Apr;30 Suppl 1:S19-23. Review.

PMID:
16570100
19.

The tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by Delta9-tetrahydrocannabinol in cultured cortical neurons.

Downer EJ, Gowran A, Murphy AC, Campbell VA.

Eur J Pharmacol. 2007 Jun 14;564(1-3):57-65. Epub 2007 Feb 22.

PMID:
17379209
20.

Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.

Hungund BL, Basavarajappa BS.

Ann N Y Acad Sci. 2004 Oct;1025:515-27. Review.

PMID:
15542757
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk